好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Safety, Tolerability, and Pharmacokinetic Parameters of 10-, 15-, and 30-Minute Intravenous Lacosamide Infusions as Short-Term Replacement Therapy in Subjects with Partial-Onset Seizures
Epilepsy/Clinical Neurophysiology (EEG)
(-)
008
Authors/Disclosures
Gregory Krauss, MD (Johns Hopkins University) Dr. Krauss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvelle. Dr. Krauss has received stock or an ownership interest from EpiWatch.
Amanda Thuringer, DO (University of Kansas Medical Center) Dr. Thuringer has nothing to disclose.
Elinor Ben-Menachem, MD, FAAN (Dept of Clinical Neuroscience) Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arvelle. Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharma. Dr. Ben-Menachem has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Acta Neurologica Scandinvica. The institution of Dr. Ben-Menachem has received research support from zogenic.
Ruta Mameniskiene, MD (Vilnius University Hospital) No disclosure on file
No disclosure on file
No disclosure on file
Melissa Brock (SCHWARZ BIOSCIENCES, Inc.) No disclosure on file
No disclosure on file